• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介孔碳酸镁与聚合物协同作用促进难溶性药物的缓释。

Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers.

作者信息

Yang Jiaojiao, Alvebratt Caroline, Zhang Peng, Zardán Gómez de la Torre Teresa, Strømme Maria, Bergström Christel A S, Welch Ken

机构信息

Division of Nanotechnology and Functional Materials, Department of Engineering Sciences, Uppsala University, Uppsala SE-75121, Sweden.

Department of Pharmacy, Uppsala Biomedical Center, Uppsala University, P.O. Box 580, Uppsala SE-751 23, Sweden.

出版信息

Int J Pharm. 2017 Jun 15;525(1):183-190. doi: 10.1016/j.ijpharm.2017.04.018. Epub 2017 Apr 8.

DOI:10.1016/j.ijpharm.2017.04.018
PMID:28396244
Abstract

The need to combat poor water solubility has increased interest in supersaturating drug delivery systems. In this study, amorphous mesoporous magnesium carbonate (MMC) was used as a drug carrier to achieve supersaturation of tolfenamic acid and rimonabant, two drug compounds with low aqueous solubility. The potential synergy between MMC and hydroxypropyl methylcellulose (HPMC), a polymer commonly included as a precipitation inhibitor in drug delivery systems, was explored with the aim of extending the time that high supersaturation levels were maintained. Release was studied under physiological conditions using USP-2 dissolution baths. A new small-scale method was developed to enable measurement of the initial drug release occurring when the MMC is immersed in the water phase. It was shown that MMC and HPMC together resulted in significant supersaturation and that the polymer enabled both the achievement of a higher API concentration and extension of the supersaturation period. The new small-scale release method showed that the release was linearly increasing with the dose and that similar release rates were observed for the two model compounds. It was hence concluded that the MMC release was diffusion limited for the compounds explored.

摘要

应对药物水溶性差的需求增加了人们对过饱和给药系统的兴趣。在本研究中,无定形介孔碳酸镁(MMC)被用作药物载体,以实现托芬那酸和利莫那班这两种水溶性低的药物化合物的过饱和。探索了MMC与羟丙基甲基纤维素(HPMC,一种在给药系统中常用作沉淀抑制剂的聚合物)之间的潜在协同作用,目的是延长维持高过饱和水平的时间。在生理条件下使用USP-2溶出浴研究释放情况。开发了一种新的小规模方法,以测量MMC浸入水相时发生的初始药物释放。结果表明,MMC和HPMC共同导致显著的过饱和,并且该聚合物能够实现更高的活性药物成分(API)浓度并延长过饱和期。新的小规模释放方法表明,释放随剂量呈线性增加,并且两种模型化合物的释放速率相似。因此得出结论,对于所研究的化合物,MMC的释放受扩散限制。

相似文献

1
Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers.介孔碳酸镁与聚合物协同作用促进难溶性药物的缓释。
Int J Pharm. 2017 Jun 15;525(1):183-190. doi: 10.1016/j.ijpharm.2017.04.018. Epub 2017 Apr 8.
2
A Modified In Situ Method to Determine Release from a Complex Drug Carrier in Particle-Rich Suspensions.一种改进的原位方法,用于测定富含颗粒的悬浮液中复杂药物载体的释放。
AAPS PharmSciTech. 2018 Oct;19(7):2859-2865. doi: 10.1208/s12249-018-1024-1. Epub 2018 Jun 6.
3
Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate.介孔碳酸镁诱导难溶性药物的过饱和
Eur J Pharm Sci. 2016 Oct 10;93:468-74. doi: 10.1016/j.ejps.2016.08.059. Epub 2016 Aug 31.
4
Impact of Physicochemical Properties of Cellulosic Polymers on Supersaturation Maintenance in Aqueous Drug Solutions.纤维素聚合物的物理化学性质对水溶液中药物的过饱和度维持的影响。
AAPS PharmSciTech. 2018 May;19(4):1860-1868. doi: 10.1208/s12249-018-0999-y. Epub 2018 Apr 10.
5
Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.基于水不溶性聚(2-羟乙基甲基丙烯酸酯)水凝胶的无定形固体分散体的过饱和度速率和剂量对动力学溶解度曲线的综合影响。
Mol Pharm. 2018 May 7;15(5):2017-2026. doi: 10.1021/acs.molpharmaceut.8b00162. Epub 2018 Apr 5.
6
Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.Eudragit EPO和羟丙基甲基纤维素对吲哚美辛无定形固体分散体的药物释放速率、过饱和度、沉淀结果及再溶解速率的影响
Int J Pharm. 2017 Oct 5;531(1):313-323. doi: 10.1016/j.ijpharm.2017.08.099. Epub 2017 Aug 24.
7
Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin.开发具有超饱和特性的缓释口服剂型的溶出度测试方法。案例示例:吲哚美辛固体分散体基质。
Int J Pharm. 2015 Jul 25;490(1-2):368-74. doi: 10.1016/j.ijpharm.2015.05.054. Epub 2015 May 26.
8
Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs.将无定形布洛芬稳定于乌索石(一种介孔碳酸镁)中,作为提高难溶性药物水溶性的一种方法。
Int J Pharm. 2014 Sep 10;472(1-2):185-91. doi: 10.1016/j.ijpharm.2014.06.025. Epub 2014 Jun 17.
9
Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation.布洛芬钠与纤维素聚合物的结合:深入探究延长过饱和的机制。
Int J Pharm. 2014 Nov 20;475(1-2):536-46. doi: 10.1016/j.ijpharm.2014.09.015. Epub 2014 Sep 16.
10
Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.由聚丙烯酸和纤维素衍生物配制的高载药量非晶态固体分散体中塞来昔布的释放改善
Mol Pharm. 2016 Mar 7;13(3):873-84. doi: 10.1021/acs.molpharmaceut.5b00798. Epub 2016 Feb 2.

引用本文的文献

1
Evaluation of Suitable Polymeric Matrix/Carriers during Loading of Poorly Water Soluble Drugs onto Mesoporous Silica: Physical Stability and In Vitro Supersaturation.难溶性药物负载于介孔二氧化硅过程中合适聚合物基质/载体的评估:物理稳定性和体外过饱和现象
Polymers (Basel). 2024 Mar 13;16(6):802. doi: 10.3390/polym16060802.
2
Metronidazole and Ketoprofen-Loaded Mesoporous Magnesium Carbonate for Rapid Treatment of Acute Periodontitis .载有甲硝唑和酮洛芬的介孔碳酸镁用于急性牙周炎的快速治疗
ACS Omega. 2023 Jul 5;8(28):25441-25452. doi: 10.1021/acsomega.3c02968. eCollection 2023 Jul 18.
3
Processability of mesoporous materials in fused deposition modeling for drug delivery of a model thermolabile drug.
介孔材料在熔融沉积成型中用于一种模型热敏药物给药的可加工性。
Int J Pharm X. 2022 Dec 17;5:100149. doi: 10.1016/j.ijpx.2022.100149. eCollection 2023 Dec.
4
Bioavailability of Celecoxib Formulated with Mesoporous Magnesium Carbonate-An In Vivo Evaluation.介孔碳酸镁载药塞来昔布的体内生物利用度评价。
Molecules. 2022 Sep 21;27(19):6188. doi: 10.3390/molecules27196188.
5
Increasing the Transport of Celecoxib over a Simulated Intestine Cell Membrane Model Using Mesoporous Magnesium Carbonate.使用中孔碳酸镁提高塞来昔布在模拟肠细胞膜模型中的传递
Molecules. 2021 Oct 21;26(21):6353. doi: 10.3390/molecules26216353.
6
3D-Printed Mesoporous Carrier System for Delivery of Poorly Soluble Drugs.用于递送难溶性药物的3D打印介孔载体系统
Pharmaceutics. 2021 Jul 18;13(7):1096. doi: 10.3390/pharmaceutics13071096.
7
In Vitro Performance and Chemical Stability of Lipid-Based Formulations Encapsulated in a Mesoporous Magnesium Carbonate Carrier.封装于介孔碳酸镁载体中的脂质制剂的体外性能及化学稳定性
Pharmaceutics. 2020 May 6;12(5):426. doi: 10.3390/pharmaceutics12050426.
8
Nanotechnology advances towards development of targeted-treatment for obesity.纳米技术在开发针对肥胖症的靶向治疗方面取得进展。
J Nanobiotechnology. 2019 Dec 16;17(1):122. doi: 10.1186/s12951-019-0554-3.
9
Exploring the Use of Amine Modified Mesoporous Magnesium Carbonate for the Delivery of Salicylic Acid in Topical Formulations: In Vitro Cytotoxicity and Drug Release Studies.探索胺改性介孔碳酸镁在局部制剂中递送水杨酸的应用:体外细胞毒性和药物释放研究。
Molecules. 2019 May 11;24(9):1820. doi: 10.3390/molecules24091820.
10
Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.一种具有介孔结构的氧化锡载体的研发,用于提高非诺贝特的溶出速率和口服相对生物利用度。
Drug Des Devel Ther. 2018 Jul 10;12:2129-2138. doi: 10.2147/DDDT.S166989. eCollection 2018.